About
Ophthalmic Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalSan Diego & Southern California
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
435
By Phase
PHASE2: 4PHASE1/PHASE2: 2
By Status
COMPLETED: 5WITHDRAWN: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Today
Hover over trial bars to see details
Recent Trials
NCT03626636Lead Sponsor
A Clinical Trial Designed To Evaluate The Safety And Exploratory Efficacy Of 1.0 Mg Luminate® (Alg-1001) As A Treatment For Non-Exudative Macular Degeneration
PHASE2Completed
42 participants
Started: Aug 1, 2017 · Completed: Apr 4, 2019
NCT02435862Lead Sponsor
A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy
PHASE2Completed
105 participants
Started: Feb 1, 2015 · Completed: Aug 10, 2017
NCT02348918Lead Sponsor
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
PHASE2Completed
218 participants
Started: Oct 13, 2014 · Completed: Jun 13, 2017
NCT02153476Lead Sponsor
A Safety And Efficacy Study Of Alg-1001 In Human Subjects With Symptomatic Focal Vitreomacular Adhesion
PHASE2Completed
45 participants
Started: Feb 28, 2014 · Completed: Jun 30, 2015
NCT01749891Lead Sponsor
A Safety And Efficacy Study Of ALG-1001 In Human Subjects With Wet Age-Related Macular Degeneration
PHASE1/PHASE2Completed
25 participants
Started: Mar 31, 2012 · Completed: Jun 7, 2013
Locations (1)
Headquarters
San Juan Capistrano, CA, United States
Map
Loading map...